XtalPi Inc.

Jan 09, 2025

UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform

Oct 10, 2024

Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform

Sep 24, 2024

XtalPi Launches Computational Chemistry Software for Drug Discovery: XMolGen and XFEP

Mar 27, 2024

XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024

Jan 30, 2024

XtalPi Unveils Ailux: A New Chapter in AI-Powered Biologics Discovery

Jan 13, 2021

XtalPi to Present at the 39th Annual J.P. Morgan Healthcare Conference

Sep 28, 2020

AI Drug R&D Startup XtalPi Announces Over 300 Million Series C Investment Led by SoftBank Vision Fund, PICC Capital, and Morningside

Mar 11, 2020

XtalPi Announces Strategic Collaboration with Porton to Offer Prediction-Guided Crystallization and Drug Solid-State Research Services